1. Home
  2. MXCT vs MPV Comparison

MXCT vs MPV Comparison

Compare MXCT & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • MPV
  • Stock Information
  • Founded
  • MXCT 1999
  • MPV 1988
  • Country
  • MXCT United States
  • MPV United States
  • Employees
  • MXCT 114
  • MPV N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MPV Finance Companies
  • Sector
  • MXCT Health Care
  • MPV Finance
  • Exchange
  • MXCT Nasdaq
  • MPV Nasdaq
  • Market Cap
  • MXCT 186.7M
  • MPV 201.1M
  • IPO Year
  • MXCT 2021
  • MPV N/A
  • Fundamental
  • Price
  • MXCT $1.75
  • MPV $20.22
  • Analyst Decision
  • MXCT Buy
  • MPV
  • Analyst Count
  • MXCT 4
  • MPV 0
  • Target Price
  • MXCT $7.50
  • MPV N/A
  • AVG Volume (30 Days)
  • MXCT 916.2K
  • MPV 25.2K
  • Earning Date
  • MXCT 11-12-2025
  • MPV 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • MPV 8.71%
  • EPS Growth
  • MXCT N/A
  • MPV N/A
  • EPS
  • MXCT N/A
  • MPV 1.71
  • Revenue
  • MXCT $34,419,000.00
  • MPV N/A
  • Revenue This Year
  • MXCT N/A
  • MPV N/A
  • Revenue Next Year
  • MXCT $14.72
  • MPV N/A
  • P/E Ratio
  • MXCT N/A
  • MPV $9.35
  • Revenue Growth
  • MXCT N/A
  • MPV N/A
  • 52 Week Low
  • MXCT $1.26
  • MPV $11.18
  • 52 Week High
  • MXCT $5.20
  • MPV $16.42
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 59.51
  • MPV 62.18
  • Support Level
  • MXCT $1.61
  • MPV $19.51
  • Resistance Level
  • MXCT $1.81
  • MPV $20.22
  • Average True Range (ATR)
  • MXCT 0.11
  • MPV 0.33
  • MACD
  • MXCT 0.02
  • MPV 0.07
  • Stochastic Oscillator
  • MXCT 86.90
  • MPV 100.00

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

Share on Social Networks: